Botulinum Toxins for Esthetic Facial Injections: A Scientific Review to Support Evidence-Based Best Practice
Related Experiment Video
Updated: Oct 8, 2025

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Wolfgang G Philipp-Dormston1,2, Dario Bertossi3, Khosrow Houschyar2
1Department of Dermatology and Dermatologic Surgery, University Witten/Herdecke, Witten, Germany.
Abstract:
Botulinum toxins (BoNT) are complex biological products. Each licensed BoNT type A (BoNTA) has its own individual characteristics resulting into different attributes, some of them being of clinical relevance. Besides profound anatomical knowledge and understanding of esthetic principles, the responsible injecting physician should be aware of those pharmaceutical and clinical properties. Especially against the background of new BoNTA formulations receiving approval by the authorities, a critical and dedicated discussion on the individual characteristics should take place, and the potential relevance on the treatment outcome should be taken into consideration.
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses

